Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01487499 · ClinicalTrials.gov registry record · Phase 3
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
A Phase 3 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 3
- Development phase
- 4
- Enrollment target
NCT01487499: Clinical Trial Phase 3 study, sponsored by University of Florida.
NCT01487499 is a Phase 3 study that was terminated before completion, run by University of Florida. The registered enrollment target is 4 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01487499, a Phase 3 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 4 participants
- Enrollment target
Study Summary
This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemotherapy and radiation therapy for patients with limited stage SCLC by comparing tumor growth and survival rates of the treatment group and compare the outcomes to historical controls 2. to implement a prospective clinical trial to test the feasibility and efficacy as measured by tumor growth and survival rates of intralesional chemotherapy for patients with recurrent SCLC after standard treatment.
Primary Outcome
The Organization for Research and Treatment of Cancer Response Evaluation Criteria in Solid Tumors (RECIST) system will be used to grade the response to therapy.
Interventions
- DRUG Cisplatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-03 |
| Phase | Phase 3 |
Why NCT01487499 stopped before completion
NCT01487499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Cisplatin is the first listed.
NCT01487499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01487499 about?
NCT01487499 is a clinical study titled "Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)". This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemother...
What is the current status of trial NCT01487499?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 4 participants. The study started on 2011-12. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01487499?
The interventions under investigation include: Cisplatin (DRUG).
Who is sponsoring clinical trial NCT01487499?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01487499's enrollment target sits among peer trials
4 1998th of 2000 higher than 2 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia